硕世生物
(688399)
| 流通市值：62.97亿 | | | 总市值：62.97亿 |
| 流通股本：8387.17万 | | | 总股本：8387.17万 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 294,693,999.69 | 496,146,582.71 | 329,915,492.31 | 810,632,720.07 |
| 交易性金融资产 | 1,358,537,596.58 | 1,475,890,382.56 | 1,628,262,992.14 | 1,137,852,516.86 |
| 应收票据及应收账款 | 50,786,882.26 | 65,888,931.16 | 55,678,822.98 | 53,894,941.97 |
| 其中：应收票据 | 40,128 | 190,377.3 | 500,000 | 72,900 |
| 应收账款 | 50,746,754.26 | 65,698,553.86 | 55,178,822.98 | 53,822,041.97 |
| 应收款项融资 | 500,016.88 | 957,049.06 | 1,257,612.11 | - |
| 预付款项 | 24,186,758.54 | 21,235,789.08 | 24,302,808.3 | 17,981,566.48 |
| 其他应收款合计 | 4,978,963.35 | 6,115,632.25 | 5,823,665.06 | 5,189,406.53 |
| 存货 | 53,153,428.7 | 52,746,082.74 | 59,168,414.06 | 67,044,790.5 |
| 其他流动资产 | 2,481,706.05 | 22,592,977.14 | 28,843,520.49 | 46,699,908.78 |
| 流动资产合计 | 1,789,319,352.05 | 2,141,573,426.7 | 2,133,253,327.45 | 2,139,295,851.19 |
| 非流动资产: | | | | |
| 长期股权投资 | 314,822,178.9 | 216,649,155.83 | 218,149,683.1 | 220,009,246.49 |
| 其他权益工具投资 | 4,138,483.28 | 4,138,483.28 | 4,138,483.28 | 4,138,483.28 |
| 其他非流动金融资产 | 230,091,118.01 | 229,622,645.19 | 234,808,800.22 | 225,846,644.93 |
| 固定资产 | 531,236,434.37 | 540,601,709.09 | 551,278,093.21 | 558,418,470.33 |
| 在建工程 | 63,178,300.8 | 28,776,566.75 | 5,011,980.36 | 4,935,051.94 |
| 使用权资产 | 9,527,541.89 | 10,924,287.37 | 12,401,114.04 | 13,881,136.59 |
| 无形资产 | 25,740,302.13 | 26,288,321.75 | 26,856,450.09 | 27,448,295.07 |
| 长期待摊费用 | 22,068,106.27 | 26,122,658.54 | 30,349,725.59 | 34,576,792.64 |
| 递延所得税资产 | 71,040,232.05 | 71,993,472.48 | 73,870,601.38 | 75,013,718.59 |
| 其他非流动资产 | 587,470,650.41 | 584,277,578.58 | 579,206,920.99 | 436,384,325.62 |
| 非流动资产合计 | 1,859,313,348.11 | 1,739,394,878.86 | 1,736,071,852.26 | 1,600,652,165.48 |
| 资产总计 | 3,648,632,700.16 | 3,880,968,305.56 | 3,869,325,179.71 | 3,739,948,016.67 |
| 流动负债: | | | | |
| 短期借款 | 414,453,559.95 | 398,766,402.12 | 366,150,685.59 | 227,689,730.37 |
| 应付票据及应付账款 | 32,759,510.75 | 14,753,534.09 | 23,186,368.66 | 23,853,281.19 |
| 应付账款 | 32,759,510.75 | 14,753,534.09 | 23,186,368.66 | 23,853,281.19 |
| 合同负债 | 19,820,900.29 | 22,186,984.11 | 25,100,145.14 | 38,757,303.5 |
| 应付职工薪酬 | 16,872,928.54 | 18,601,378.67 | 18,174,608.51 | 16,141,706.14 |
| 应交税费 | 3,346,575.9 | 2,648,244.77 | 2,329,442.18 | 1,976,128.14 |
| 其他应付款合计 | 45,326,691.8 | 47,617,198.82 | 44,932,125.19 | 52,592,305.53 |
| 一年内到期的非流动负债 | 4,133,599.23 | 5,024,783.14 | 2,037,269 | 5,637,655.76 |
| 其他流动负债 | 2,558,942.38 | 2,587,197.61 | 3,084,775.96 | 1,170,347.22 |
| 流动负债合计 | 539,272,708.84 | 512,185,723.33 | 484,995,420.23 | 367,818,457.85 |
| 非流动负债: | | | | |
| 长期借款 | 32,000,000 | - | - | - |
| 租赁负债 | 4,343,099.91 | 5,578,588.88 | 9,713,273.42 | 7,221,290.78 |
| 长期应付职工薪酬 | 50,000,000 | 50,000,000 | 50,000,000 | 50,000,000 |
| 递延收益 | 55,425,912.91 | 58,286,904.51 | 61,165,026.79 | 64,276,240.67 |
| 非流动负债合计 | 141,769,012.82 | 113,865,493.39 | 120,878,300.21 | 121,497,531.45 |
| 负债合计 | 681,041,721.66 | 626,051,216.72 | 605,873,720.44 | 489,315,989.3 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 83,871,721 | 83,871,721 | 56,670,082 | 56,670,082 |
| 资本公积 | 633,884,069.77 | 633,884,069.77 | 661,060,070.73 | 661,060,070.73 |
| 其他综合收益 | -6,036,786.86 | -4,715,480.39 | -4,982,289.21 | -4,982,289.21 |
| 盈余公积 | 29,310,000 | 29,310,000 | 29,310,000 | 29,310,000 |
| 未分配利润 | 2,226,561,974.59 | 2,512,566,778.46 | 2,521,393,595.75 | 2,508,574,163.85 |
| 归属于母公司股东权益合计 | 2,967,590,978.5 | 3,254,917,088.84 | 3,263,451,459.27 | 3,250,632,027.37 |
| 股东权益合计 | 2,967,590,978.5 | 3,254,917,088.84 | 3,263,451,459.27 | 3,250,632,027.37 |
| 负债和股东权益合计 | 3,648,632,700.16 | 3,880,968,305.56 | 3,869,325,179.71 | 3,739,948,016.67 |
| 公告日期 | 2025-10-25 | 2025-08-09 | 2025-04-30 | 2025-04-19 |
| 审计意见(境内) | | | | 标准无保留意见 |